Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
Crossref DOI link: https://doi.org/10.1007/s10549-021-06223-6
Published Online: 2021-04-27
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kazmi, Shayma http://orcid.org/0000-0001-6591-2965
Chatterjee, Debanjana
Raju, Dheeraj
Hauser, Rob
Kaufman, Peter A.
Text and Data Mining valid from 2021-04-27
Version of Record valid from 2021-04-27
Article History
First Online: 27 April 2021